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Abstract 
Background: Malaria is a major public health problem and an important cause of maternal and infant morbidity in 
sub-Saharan Africa, including Ethiopia. Early and accurate diagnosis of malaria with effective treatment is the best 
strategy for prevention and control of complications during pregnancy and infant morbidity and mortality. However, 
laboratory diagnosis has relied on the identification of malaria parasites and parasite antigens in peripheral blood 
using Giemsa-stained microscopy or rapid diagnostic tests (RDTs) which lack analytical and clinical sensitivity. The aim 
of this study was to evaluate the performance of loop-mediated isothermal amplification (LAMP) for the diagnosis of 
malaria among malaria suspected pregnant women in Northwest Ethiopia.
Methods: A cross sectional study was conducted from January to April 2016. Pregnant women (n = 87) suspected of 
having malaria at six health centres were enrolled. A venous blood sample was collected from each study subject, and 
analysed for Plasmodium parasites by microscopy, RDT, and LAMP. Diagnostic accuracy outcome measures (sensitivity, 
specificity, predictive values, and Kappa scores) of microscopy, RDT and LAMP were compared to nested polymerase 
chain reaction (nPCR) as the gold standard. Specimen processing and reporting times were documented.
Results: Using nPCR as the gold standard technique, the sensitivity of microscopy and RDT was 90 and 70%, and the 
specificity was 98.7 and 97.4%, respectively. LAMP assay was 100% sensitive and 93.5% specific compared to nPCR.
Conclusions: This study showed higher sensitivity of LAMP compared to microscopy and RDT for the detection of 
malaria in pregnancy. Increased sensitivity and ease of use with LAMP in point-of-care testing for malaria in pregnancy 
was noted. LAMP warrants further evaluation in intermittent screening and treatment programmes in pregnancy.
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Background
Plasmodium falciparum is the principal cause of severe 
malaria while Plasmodium vivax is increasingly recog-
nized as capable of causing severe disease [1–4]. Accord-
ing to the latest World Health Organization report 
of 2015, there were an estimated 214 million cases of 
malaria worldwide with 438,000 deaths. Ninety per cent 
of the deaths occurred in sub-Saharan Africa where preg-
nant women and children are significantly affected [1].
Every year about 30 million African women in malaria-
endemic areas become pregnant and are at risk of infec-
tion with malaria, and an estimated 75,000–200,000 infant 
deaths are reported due to malaria infection in pregnancy 
[5, 6]. Malaria, particularly due to P. falciparum, in preg-
nant women increases the risk of maternal death, mis-
carriage, stillbirth and neonatal death [7, 8]. The impact 
of malaria during pregnancy may vary within a country 
depending on the intensity of malaria transmission. In 
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areas of seasonal malaria transmission, pregnant women 
are three times more likely to suffer from severe malaria 
as compared to non-pregnant counterparts. In areas of 
stable malaria, adult pregnant women would have consid-
erable acquired immunity and infection during pregnancy 
typically does not cause symptomatic malaria. The effect 
of malaria in pregnancy is primarily low birth weight and 
maternal anaemia [9, 10].
The World Health Organization (WHO) recommends a 
three-pronged approach to reduce the burden of malaria 
in pregnancy: (1) provision and promotion of insecticide 
treated bet nets (ITN) or long-lasting insecticide- treated 
bed nets (LLINS); (2) administration of intermittent 
preventive treatment with sulfadoxine–pyrimethamine 
(IPTp-SP) after the first trimester of pregnancy in areas 
with stable malaria transmission; and (3) prompt diag-
nosis and appropriate treatment of malaria [5, 11]. How-
ever, because of rising P. falciparum resistance to SP in 
sub-Saharan regions, the use of rapid diagnostic tests to 
screen women for malaria at the first or each antenatal 
visit and then treat is likely more sustainable than IPTp 
without diagnosis [12].
Early and accurate diagnosis with effective treatment is 
the best strategy to decrease malaria-related pregnancy 
complications and infant mortality. The current malaria 
diagnostic methods include Giemsa-based microscopy, 
rapid diagnostic tests (RDTs), polymerase chain reaction 
(PCR) and placental histology depending on the setting 
[13]. The poor performance of routine malaria diagnostic 
techniques including RDTs and microscopy contribute to 
the burden of malaria in pregnant women [14, 15]. This 
is in large part due to the sequestration of the parasite in 
the placenta making the parasitaemia lower than usual 
in the peripheral blood. Therefore, nPCR which targets 
the small subunit ribosomal RNA (ssrRNA) is the better 
alternative diagnostic technique due to its high sensitiv-
ity (as low as 0.1 parasite/µl of whole blood). However, 
nPCR it is not widely used for the diagnosis of malaria 
in resource-limited settings as it requires a very well-
equipped laboratory, and the cost of diagnosis is more 
expensive [16, 17].
Loop-mediated isothermal amplification (LAMP) is a 
simpler molecular procedure and better alternative for 
the field than nPCR [18, 19]. LAMP has many operational 
advantages over PCR including: (1) the acceptability of a 
crude sample preparation; (2) minimal capital equipment 
requirements; (3) rapid time to obtain a result; (4) lower 
cost; and (5) technically less complex than PCR [20].
Methods
Study area
The study was conducted at Kola Diba, Girargie, Aymba, 
Azezo, Tseda, and Sanja Health Centres, which are 
located in North Gondar, Amhara Regional State, Ethio-
pia. The district covers an area of 1270  km with a total 
population of about 263,000 people approximately 
700  km north of Addis Ababa close to Lake Tana. The 
ethnic group which predominates in this region are the 
Amhara people. The district sits at an altitude between 
1750 and 2100  m above sea level. Malaria is the most 
prevalent seasonal disease in the area, and is the second 
most common reportable disease at the health centre. 
Both seasonal Plasmodium vivax and year-long P. falci-
parum exist in the area [21, 22]. Peak malaria transmis-
sion occurs from October to December.
Study design
A cross-sectional study was conducted among malaria 
suspected pregnant women at six health centres in 
Northwest Ethiopia from January to April (local dry sea-
son), 2016. Study participants were recruited consecu-
tively (convenience sampling) and a total of 87 pregnant 
women with signs and symptoms consistent with malaria 
were enrolled. Pregnant women who provided the 
required laboratory sample for the study were included in 
the study. Those subjects who were severely ill according 
to WHO criteria and/or had received anti-malarial drugs 
during the past 4  weeks prior to study commencement 
were excluded.
Data collection
Demographic profiles and clinical data were collected at 
the health centre antenatal clinic using an interview-based 
questionnaire translated into the vernacular language that 
the participant could understand. In addition, two millilit-
ers of venous blood was collected from each study partici-
pant using an EDTA anti-coagulated test tube. Soon after 
venous blood collection, a drop of blood was taken for 
the RDT, then two separate drops of blood were placed 
on a frosted microscopic glass slide to prepare both thin 
and thick blood films, and another two separate drops of 
blood was placed on Whatman filter for nPCR. The rest 
of the blood was kept at 2–8 °C at the health centre then 
transported to the Medical Parasitology Laboratory, Uni-
versity of Gondar on weekly basis to be kept frozen until 
analysed with LAMP. Blood films were processed, and 
parasite detection and parasitaemia level was determined 
according to WHO standards [23]. CareStart™ HRP2/
PLDH COMBO (Pf/Pan) detection kits were used for 
RDT testing. CareStart™ Pf/Pan targets histidine rich pro-
tein 2 for P. falciparum and lactate dehydrogenase for the 
diagnosis of non-falciparum species.
LAMP process and detection of malaria parasites
Loopamp™ malaria Pan/Pf detection kits (Eiken Chemi-
cals, Tokyo, Japan) which detect mitochondrial DNA 
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were used to amplify Plasmodium/P. falciparum DNA. 
The preparation of the LAMP mixture, sample running 
and detection was performed as described previously 
[24]. Briefly, the parasite DNA was extracted by a “boil 
and spin” method where 60 μl of EDTA blood was added 
to 60 μl of extraction solution (400 mM NaCl, 40 mM Tris 
pH 6.5, and 0.4% sodium dodecyl sulfate) in an Eppen-
dorf tube, heated for 5  min at 95  °C with a water bath, 
then centrifuged at 10,000× g for 3  min. The superna-
tant (30 ml) was pipetted into a dilution tube containing 
345 μl of sterile water, and finally 30 μl of diluted DNA 
sample was used in the LAMP assay. Reaction tubes con-
taining extracted DNA sample were incubated at 65  °C 
in a water bath for 40  min. Amplification was detected 
by naked eye based on turbidity. Two additional blinded 
laboratory technicians read the turbidity observed at the 
end of the LAMP reaction for the final consensus result.
Nested PCR process and detection of malaria parasites
Genomic DNA was extracted from dried blood on What-
man filter paper 903 (GE Healthcare) and nPCR analysis 
was performed as described previously [25].
Data analysis
Data were entered into Microsoft Excel program and 
then analysed with SPSS version 20. Sensitivity, specific-
ity, predictive values and Cohen’s kappa coefficient were 
determined using SISA online statistical software [26]. 
All discordant specimens were repeated by LAMP and/
or nPCR.
Results
A total of 87 malaria suspected pregnant women with the 
mean (SD) age of 27.43 (+5.2) years were enrolled into 
the study, of which 50.6% (45/87) had a previous malaria 
history (Table  1). The majority (52.9%) of patients were 
in the 25–30 age group. Second (41.4%) and third tri-
mester (41.4%) pregnancies were more common than 
first trimester (17.2%). Close to three quarters (74.7%) 
of patients were multigravida. The overall malaria posi-
tivity rate among the study participants by nPCR was 
11.5% (10/87). Ten malaria positive patients (11.5%) were 
detected by Giemsa microcopy with an overall median 
parasitaemia density of 3380/μl (parasitaemia range 400–
24,760/μl). Five of the Giemsa microscopy positives were 
P. falciparum (parasitaemia density minimum/maximum: 
400/7840 per μl); three were P. vivax (parasitaemia den-
sity minimum/maximum: 520/24,760  per  μl), and two 
were mixed infections of P. falciparum and P. vivax (para-
sitaemia density minimum/maximum: 520/5360 per μl). 
LAMP identified 15 positive (17.2%) specimens and RDT 
9 (10.3%) positives. A higher positivity rate of both single 
and mixed Plasmodium species infection were reported 
by LAMP than other diagnostic techniques used in this 
study (Table 2).
Using nPCR as the gold standard, LAMP had the high-
est sensitivity (100%; 95% CI 100) compared to micros-
copy (90%; 95% CI 66.3–113.7) and RDT (70%; 95% CI 
33.8–106.2). Microscopy had the greatest specificity 
(98.7%; 95% CI 96.5–101.9) compared to RDT (97.4%; 
95% CI 92.9–101.9) and LAMP (93.5%; 95% CI 86.5–
100.5). There were five discordant results between nPCR 
and LAMP where five of them were negative by nPCR 
but positive by LAMP. There was also one study partici-
pant with a parasitaemia load of 520/μl negative only by 
nPCR. In this study, LAMP showed better sensitivity but 
lower specificity than microscopy and RDTs using nPCR 
as the gold standard (Table  3). Discordant results are 
itemized in Table  4. RDTs had the quickest turnaround 
time at 23  min compared to LAMP (60  min), micros-
copy (60 min), and nPCR (130 min) (Table 5). Both RDT 
and LAMP can be performed at the point of care (com-
munity-based testing) without the need for laboratory 
facilities.
Discussion
Pregnant women have an increased susceptibility to 
infection by Plasmodia spp. Parasites sequestered in 
the placenta are sometimes not detectable in peripheral 
blood smears by Giemsa microscopy [14]. Infection can 
result in maternal anaemia, prematurity and intrauterine 
growth retardation (IUGR) and infant low birth weight 
(LBW) [6]. A study from Cameroon revealed that 20.9% 
of pregnant women who had placental malaria were neg-
ative by peripheral blood smear [27].
Malaria remains a leading cause of morbidity and mor-
tality especially among pregnant women and children 
in the developing world [1]. In the current study, the 
rate of malaria positivity was lower than a similar study 
conducted in Cameroon which had 21.9% positivity by 
microscopy [27]; Ghana, 19, 34, and 53% positivity by 
microscopy, RDTs and PCR, respectively [28]; Nigeria, 
27 and 30% positivity by RDTs and microscopy, respec-
tively [29]; Mozambique, 18.7, 15.4 and 44.8% positivity 
by RDTs, microscopy and quantitative PCR, respectively 
[14]. The discrepancy in positivity may be due to the 
seasonality of transmission levels in Ethiopia. The rate 
of malaria may vary depending on the district, intensity 
of malaria transmission, season, density of parasitae-
mia, immunity level acquired, administration of malaria 
chemoprophylaxis, and diagnostic methods used [27, 
30–33]. Although the current study area was reported 
to be endemic to malaria, its transmission was low dur-
ing the dry season. Of note, malaria transmission has 
decreased over time in this region presumably due to the 
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introduction of WHO-endorsed control strategies except 
the deployment of intermittent preventive therapy [21].
In the current study, age group, trimester and parity 
were not statistically associated with malaria infection. 
Based on nPCR results, seventy percent (7/10) of malaria 
infected pregnant women were multigravida. In contrast, 
a study from Gabon revealed that primigravida and 
young pregnant women were associated with increased 
malaria susceptibility. Although not statistically sig-
nificant, based on microscopy results, primigravida 
women demonstrated a higher median parasite density 
(5200  parasites/μl) than multigravida (1560  parasites/
μl) [34]. This is similar to a report from Nigeria, where 
primigravida women demonstrated higher parasitaemia 
than multigravida women [35].
Polymerase chain reaction (PCR) in its various formats 
has emerged as the most sensitive method able to detect 
low levels of parasites in the blood especially in this set-
ting [36, 37]. However, PCR requires high capital invest-
ment costs, service agreements, reagent supplies, and 
trained staff in molecular technologies with robust qual-
ity assurance programmes. LAMP while being molecular 
in nature permits crude, easy-to-perform DNA extrac-
tion and visual detection even possible in the field. Pre-
vious studies from Ethiopia and Thailand revealed that 
a rapid and user friendly LAMP had comparable perfor-
mance to nPCR for the diagnosis of malaria in the general 
population [19, 24]. The current study also indicated that 
LAMP had better sensitivity (100%) than RDTs (70%) and 
Giemsa microscopy (90%) for the diagnosis of malaria in 
pregnant women. Increased sensitivity is essential to the 
malaria eradication campaign especially in populations 
such as pregnant women where low levels of infection go 
undetected.
The current study showed lower specificity of LAMP 
(93.5%) than RDTs and Giemsa microscopy. This result 
was in line with a study conducted in Bangladesh where 
Table 1 Demographic and clinical data of the study particpants
a Parasite positivity is determined by nPCR
Variable Frequencya Pearson Chi Square 
(p value)
Positive: N (%) Negative: N (%)
Age
 18–24 3 (13.0) 20 (87.0) 1.05 (0.789)
 25–30 5 (10.9) 41 (89.1)
 31–35 1 (7.1) 13 (92.9)
 36+ 1 (25.0) 3 (75.0)
Previous malaria history
 Yes 5 (11.4) 39 (88.6) 0.001 (0.969)
 No 5 (11.6) 38 (88.4)
Trimester
 First 2 (13.3) 13 (86.7) 0.61 (0.74)
 Second 5 (13.9) 31 (86.1)
 Third 3 (8.3) 33 (91.7)
Gravid
 Primigravidae 2 (9.1) 20 (90.9) 0.167 (0.683)
 Multigravidae 8 (12.3) 57 (87.7)
Table 2 Malaria positivity rate by  diagnostic techniques 
among the study participants
Results Diagnostic tool
Microscopy RDTs LAMP nPCR
Pf 5 3 5 7
Pv 3 3 5 2
Pf + Pv 2 3 5 1
Total positives 10 9 15 10
Total negatives 77 78 72 77
Table 3 Performance characteristics of  Microscopy, RDTs 












Microscopy 90 (66.3–113.7) 98.7 (96.5–
101.9)
90 98.7 0.887
RDTs 70 (33.8–106.2) 97.4 (92.9–
101.9)
77.8 96.2 0.705
LAMP 100 (100) 93.5 (86.5–
100.5)
66.7 100 0.768
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LAMP revealed lower specificity (58.3%) than micros-
copy and RDT (both 100%) when compared with nPCR 
[18]. In the current study, there were five discordant 
results between LAMP and nPCR in which five sam-
ples positive by LAMP ended up negative by nPCR. This 
result was similar to a study conducted in Thailand where 
four LAMP positive results were negative by nPCR [38]. 
These authors suggested the need for a more sensitive 
PCR technique to accurately evaluate the performance 
of LAMP. Indeed, the role of nPCR as the bona fide gold 
standard could be questioned in this study as it relied on 
filter paper samples which may be subject to DNA degra-
dation in transport to Canada from Ethiopia. DNA deg-
radation on filter paper may ultimately explain the lower 
kappa value between nPCR and LAMP versus nPCR and 
microscopy. In support of this supposition, one specimen 
was positive by all three methods except nPCR. Thus, 
additional LAMP positive cases may be true positives and 
warrant treatment. However, others have reported that 
genomic DNA is stable on filter papers over time mak-
ing this less likely a contributing factor to the discordance 
observed [39]. All discordant specimens were repeated by 
nPCR and/or LAMP to confirm the discrepancy. It is also 
possible that LAMP resulted in false positive amplifica-
tion due to contamination as observed previously in this 
setting [24]. To limit this confusion, future studies should 
attempt LAMP and reference PCR on the same specimen 
at the field site to remove the confounder of filter paper 
versus fresh blood.
In the current study, two samples which were negative 
by RDTs ended up positive by LAMP, Giemsa microscopy 
and nPCR. For accurate diagnosis of malaria with RDTs, 
at least 100–500 parasites/μl of whole blood are required 
in peripheral blood. This was supported by a study from 
Tanzania which revealed that lower density of malaria 
parasitaemia is highly associated with the negative result 
of RDTs [32]. In the present study, malaria parasitaemia 
level in these two samples was 400 and 640  parasites/
μl. However, the performance of RDTs could be also be 
affected by incorrectly reading faint positive or invalid 
results as negative [40]. There was one sample which was 
positive for P. falciparum only by RDTs. Histidine rich 
protein-2 (HRP-2) antigen could persist for a long time 
even after effective treatment, giving false positive RDT 
test results in the absence of active P. falciparum infec-
tion [41].
Conclusions
Pregnant women are more vulnerable to malaria, har-
bour low level infections, and suffer malaria related com-
plications themselves and to the neonate. It is important 
to use a highly sensitive, field-friendly detection method 
[41]. LAMP with its superior sensitivity to traditional 
lateral flow RDTs has the potential to replace RDTs and 
improve detection of Plasmodium parasites in intermit-
tent screening programmes during pregnancy.
Abbreviations
RDT: rapid diagnostic test; LAMP: loop mediated isothermal amplification.
Table 4 Discordant analysis for  microscopy, RDT, LAMP and  nPCR for  malaria diagnosis in  malaria suspected pregnant 
women
Pan all species of malaria except P. falciparum (LAMP and RDT readouts do not discriminate between non-falciparum species)
























Table 5 Total turnaround time required for  the diagnosis 
of malaria with diagnostic tools among study participants 
at Kola Diba health center
Diagnostic 
tools









RDTs 2 21 23
Microscope 40 20 60
LAMP 5 55 60
nPCR 60 250 310
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